Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites

Details for Australian Patent Application No. 2005313386 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Smid, Pieter; Van Hes, Roelof; Kruse, Cornelis G.; Tulp, Martinus Th.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005313386

PCT Pub. Number WO2006/061372

Priority 04106350.4 07.12.04 EP; 60/633,449 07.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

International Classifications

C07D 319/18 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 265/36 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/82 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 311/18 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 321/10 (2006.01) Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/061372 Priority application(s): WO2006/061372

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313387-Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

2005313380-Pyrrolidin-2-one derivatives for use as DP1 receptor agonists